Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
367-01-007 ISMRM Abstract

The Role of Low Glycaemic Index Diets in Metabolic Disease Prevention: Insight From a Randomized Cross-over Study in MASLD

Primary: Body - Liver
Secondary: Body - Metabolism
367-01-007 · Fuel and Function: Metabolism in the Body · Monday, 11 May, 8:20 AM–9:15 AM · Digital Posters Row H
Keywords: Metabolism Liver MRS Fat saturation MASLD
Accepted
Stephen Bawden 1,2,3,4, Amina Al-Awadi3,4,5,6, Jane I Grove3, Moira A Taylor3,7, Penny Gowland8,9, Guruprasad P Aithal3,4
1Department of Medical Physics and Clinical Engineering, Swansea Bay University Health Board, Swansea, United Kingdom
2Institute of Life Sciences, Medical School, Swansea University, Swansea, United Kingdom
3NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust and the University of Nottingham, Nottingham, United Kingdom
4Nottingham Digestive Diseases Centre, Translational Medical Sciences, School of Medicine, University of Nottingham, Nottingham, United Kingdom
5Al-Sabah Hospital, Ministry of Health, Civil Service Commission, Kuwait City, Kuwait
6Clinical Care Research and Trials Unit, Dasman Diabetes Institute, Kuwait City, Kuwait
7The David Greenfield Human Physiology Laboratory, School of Life Sciences, Faculty of Medicine and Health Sciences, University of Nottingham, Nottingham, United Kingdom
8Sir Peter Mansfield Imaging Centre, University of Nottingham, Nottingham, United Kingdom
9NIHR Nottingham Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom
Presenting Author: Stephen Bawden

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. NCD Risk Factor Collaboration (NCD-RisC), ‘Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults’, Lancet Lond. Engl., vol. 403, no. 10431, pp. 1027–1050, Mar. 2024, doi: 10.1016/S0140-6736(23)02750-2. [doi]
2. Z. Younossi et al., ‘Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis’, Hepatol. Baltim. Md, vol. 69, no. 6, pp. 2672–2682, June 2019, doi: 10.1002/hep.30251. [doi]
3. J. Liu et al., ‘Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis’, Chin. Med. J. (Engl.), vol. 135, no. 14, pp. 1682–1691, July 2022, doi: 10.1097/CM9.0000000000002277. [doi]
4. M. E. Rinella et al., ‘A multisociety Delphi consensus statement on new fatty liver disease nomenclature’, Hepatol. Baltim. Md, vol. 78, no. 6, pp. 1966–1986, Dec. 2023, doi: 10.1097/HEP.0000000000000520. [doi]
5. B. J. Perumpail, R. Cholankeril, E. R. Yoo, D. Kim, and A. Ahmed, ‘An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease’, Dis. Basel Switz., vol. 5, no. 4, p. 23, Oct. 2017, doi: 10.3390/diseases5040023. [doi]
6. E. M. McCarthy and M. E. Rinella, ‘The role of diet and nutrient composition in nonalcoholic Fatty liver disease’, J. Acad. Nutr. Diet., vol. 112, no. 3, pp. 401–409, Mar. 2012, doi: 10.1016/j.jada.2011.10.007. [doi]
7. S. Bawden et al., ‘Increased liver fat and glycogen stores after consumption of high versus low glycaemic index food: A randomized crossover study’, Diabetes Obes. Metab., vol. 19, no. 1, pp. 70–77, Jan. 2017, doi: 10.1111/dom.12784. [doi]
8. M. C. Stephenson et al., ‘Variability in fasting lipid and glycogen contents in hepatic and skeletal muscle tissue in subjects with and without type 2 diabetes: a 1H and 13C MRS study’, NMR Biomed., vol. 26, no. 11, pp. 1518–1526, Nov. 2013, doi: 10.1002/nbm.2985. [doi]
9. G. Hamilton et al., ‘Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification’, J. Magn. Reson. Imaging JMRI, vol. 30, no. 1, pp. 145–152, July 2009, doi: 10.1002/jmri.21809. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/367-01-007